Business Description
Description
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.16 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 1.33 | |||||
| Debt-to-EBITDA | -0.52 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 24.6 | |||||
| 3-Year EPS without NRI Growth Rate | 25.3 | |||||
| 3-Year FCF Growth Rate | 23 | |||||
| 3-Year Book Growth Rate | -39 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.58 | |||||
| 9-Day RSI | 17.41 | |||||
| 14-Day RSI | 24.78 | |||||
| 6-1 Month Momentum % | -26.92 | |||||
| 12-1 Month Momentum % | -24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.38 | |||||
| Quick Ratio | 2.38 | |||||
| Cash Ratio | 1.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.6 | |||||
| Shareholder Yield % | -43.56 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -253.83 | |||||
| ROA % | -86.79 | |||||
| ROIC % | -255.07 | |||||
| ROC (Joel Greenblatt) % | -1450.96 | |||||
| ROCE % | -204.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5 | |||||
| EV-to-EBIT | -1.68 | |||||
| EV-to-EBITDA | -1.7 | |||||
| EV-to-FCF | -1.66 | |||||
| Price-to-Net-Current-Asset-Value | 1.5 | |||||
| Earnings Yield (Greenblatt) % | -59.52 | |||||
| FCF Yield % | -56.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AdAlta Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | -0.011 | ||
| Beta | 0.06 | ||
| Volatility % | 37.57 | ||
| 14-Day RSI | 24.78 | ||
| 14-Day ATR (A$) | 0.00066 | ||
| 20-Day SMA (A$) | 0.01725 | ||
| 12-1 Month Momentum % | -24 | ||
| 52-Week Range (A$) | 0.013 - 0.041 | ||
| Shares Outstanding (Mil) | 631.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AdAlta Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AdAlta Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
AdAlta Ltd Frequently Asked Questions
What is AdAlta Ltd(ASX:1AD)'s stock price today?
The current price of ASX:1AD is A$0.02. The 52 week high of ASX:1AD is A$0.04 and 52 week low is A$0.01.
When is next earnings date of AdAlta Ltd(ASX:1AD)?
The next earnings date of AdAlta Ltd(ASX:1AD) is .
Does AdAlta Ltd(ASX:1AD) pay dividends? If so, how much?
AdAlta Ltd(ASX:1AD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers